3-Octanol

3-Octanol

SCHEMBL6826458

CCCCC[C@H](O)CC

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
3-Octanol SCHEMBL6826944 1.00
3-Octanol SCHEMBL112339 1.00
SCHEMBL6298504 0.97 GPR84 (0.58)
SCHEMBL14396082 0.97 GPR84 (0.58)
SCHEMBL378964 0.97 GPR84 (0.58)
SCHEMBL10436370 0.97 GPR84 (0.58)
SCHEMBL194832 0.97 GPR84 (0.58)
SCHEMBL2609783 0.97 GPR84 (0.58)
SCHEMBL22910980 0.97 GPR84 (0.58)
SCHEMBL378906 0.97 GPR84 (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12390437-B2 Itaconic acid derivatives and uses thereof intreating an inflammatory disease or a disease associated with an undesirable immune response SITRYX THERAPEUTICS LIMITED (GB) 2025-08-19 US disclosed
EP-3962602-B1 ITACONIC ACID DERIVATIVES AND USES THEREOF IN TREATING AN INFLAMMATORY DISEASE OR A DISEASE ASSOCIATED WITH AN UNDESIRABLE IMMUNE RESPONSE SITRYX THERAPEUTICS LTD (GB) 2025-06-25 EP disclosed
US-20220265595-A1 ITACONIC ACID DERIVATIVES AND USES THEREOF INTREATING AN INFLAMMATORY DISEASE OR A DISEASE ASSOCIATED WITH AN UNDESIRABLE IMMUNE RESPONSE SITRYX THERAPEUTICS LIMITED (GB) 2022-08-25 US disclosed
US-11369617-B2 Prostacyclin analogue formulations CAMURUS AB (SE) 2022-06-28 US disclosed
US-20190255068-A1 PROSTACYCLIN ANALOGUE FORMULATIONS CAMURUS AB (SE) 2019-08-22 US disclosed
WO-2018050864-A1 PROSTACYCLIN ANALOGUE FORMULATIONS CAMURUS AB (SE) 2018-03-22 WO disclosed
US-9102660-B2 Process of making prostacyclin compounds with linker thiol and pegylated forms United Therapeutics Corporaiton (US) 2015-08-11 US disclosed
WO-2014160638-A1 PROCESS OF MAKING PROSTACYCLIN COMPOUNDS WITH LINKER THIOL AND PEGYLATED FORMS UNITED THERAPEUTICS CORPORATION (US) 2014-10-02 WO disclosed
US-20140288314-A1 PROCESS OF MAKING PROSTACYCLIN COMPOUNDS WITH LINKER THIOL AND PEGYLATED FORMS UNITED THERAPEUTICS CORPORATION (US) 2014-09-25 US disclosed
US-20130210704-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T GLOBAL INC. (US) 2013-08-15 US disclosed
CN-1278675-C Granular material comprising polyhydroxyalkanoate and method for producing the same CANON KK (JP) 2006-10-11 CN disclosed
WO-2004111041-A1 PYRROLIDINE, THIAZOLIDINE AND OXAZOLIDINE COMPOUNDS WHICH INHIBIT DIPEPTIDYL PEPTIDASE-IV (DPP) FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-12-23 WO disclosed
CN-1431041-A Granular material comprising polyhydroxyalkanoate and method for producing the same CANON KK (JP) 2003-07-23 CN disclosed
CN-1028033-C Naphthalene compound and liquid crystal composition containing the same MITSUI PETROCHEMICAL IND (JP) 1995-03-29 CN disclosed
US-5385833-A Enzymatic synthesis of alcohols from carbonyl compounds THE SCRIPPS RESEARCH INSTITUTE (US) 1995-01-31 US disclosed
US-5230802-A Liquid ion exchanger of alkyl 2,3-bis(alkanoyloxy)butanediote and ion exchange process PHILIP MORRIS INCORPORATED (US) 1993-07-27 US disclosed
US-5141668-A NAPHTHALENE COMPOUND AND LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) 1992-08-25 US disclosed
CN-1038275-A Naphthalene compound and contain the liquid-crystal composition of this thing MITSUI PETROCHEMICAL IND (JP) 1989-12-27 CN disclosed
EP-0341922-A2 Naphthalene compound and liquid crystal composition containing the same MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1989-11-15 EP disclosed